Arecor Therapeutics (LSE:AREC) FCF Yield % : -13.35 (As of May. 21, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Arecor Therapeutics's Trailing 12-Month Free Cash Flow is £-5.99 Mil, and Market Cap is £44.87 Mil. Therefore, Arecor Therapeutics's FCF Yield % for today is -13.35%.

The historical rank and industry rank for Arecor Therapeutics's FCF Yield % or its related term are showing as below:

LSE:AREC' s FCF Yield % Range Over the Past 10 Years
Min: -21.07 Med: -9.98 Max: -1.64
Current: -13.35

During the past 7 years, the highest FCF Yield % of Arecor Therapeutics was -1.64%. The lowest was -21.07%. And the median was -9.98%.

LSE:AREC's FCF Yield % is ranked better than
51.35% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs LSE:AREC: -13.35

Arecor Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -51.62%.

Arecor Therapeutics FCF Yield % Historical Data

The historical data trend for Arecor Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics FCF Yield % Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-4.96

-15.14

-10.72

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial					-6.77	-9.55	-18.16	-12.76	-5.36

Competitive Comparison of Arecor Therapeutics's FCF Yield %

For the Biotechnology subindustry, Arecor Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's FCF Yield % falls into.

Arecor Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Arecor Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-5.992	/	55.894275
	=	-10.72%

Arecor Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.499	*	2	/	55.894275
	=	-5.36%

Arecor Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Arecor Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.